Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly

Low-grade Inflammation Clinical Trial

Official title:
Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly.

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the ability of a blend of berries and probiotics in reducing low-grade inflammation and intestinal permeability in the elderly. The intervention period is one month. Blood and fecal samples will be collected for analysis at baseline and at the end of the intervention with the aim to analyse possible changes in different parameters at the two timepoints. The participants will also be asked to keep a study diary throughout the study period for the documentation of their intestinal health and as a means for checking compliance.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Increased Intestinal Permeability
Inflammation
Low-grade Inflammation

Clinical Trial Details

NCT number	NCT02342496
Study type	Interventional
Source	Probi AB
Contact
Status	Completed
Phase	N/A
Start date	January 2015
Completion date	December 4, 2015

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02011672` - Effect of Milk Ingredients on Glucose Regulation and Inflammation	N/A
Completed	`NCT00860197` - Immune Benefits of Coffee	N/A
Active, not recruiting	`NCT01390688` - Brain-derived Neurotrophic Factor and Cogntive Function	N/A
Completed	`NCT01414647` - The Health Effect of Diet Rich in Nordic Berries	N/A
Not yet recruiting	`NCT06355544` - Individual Factors Related to Chronic Low-grade Inflammation and Cardiometabolic Disease Risk